Stemson Therapeutics

Geoff Hamilton, Co-Founder and CEO

Oct. 14 | 9:30am | BlueRock Therapeutics Ballroom

San Diego, CA


In-person Presentation

Stemson Therapeutics is a preclinical-stage cell therapy company founded in 2018 with a mission to cure hair loss by leveraging the regenerative power of induced pluripotent stem cells (iPSCs). Stemson uses iPSCs to regenerate the critical cells required to grow hair and which are damaged or depleted in patients suffering from hair loss. The iPSC-derived cells are used to grow de novo hair follicles, offering a new supply of hair to treat people suffering from various forms of alopecia. Today, there are no available treatments capable of growing new hair follicles, while millions of people continue to suffer the mental effects of hair loss. Stemson’s world class team of scientists, advisors, and collaborators are passionate about delivering a scientifically-based, clinically tested cure for hair loss to the millions of sufferers who seek help for their condition.

By using this website you agree to accept our Privacy Policy and Terms & Conditions